Cargando…
Giant cell arteritis: reviewing the advancing diagnostics and management
Giant Cell Arteritis (GCA) is well known to be a critical ischaemic disease that requires immediate medical recognition to initiate treatment and where one in five people still suffer visual loss. The immunopathophysiology has continued to be characterised, and the influencing of ageing in the devel...
Autores principales: | Bilton, Edward J., Mollan, Susan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927059/ https://www.ncbi.nlm.nih.gov/pubmed/36788362 http://dx.doi.org/10.1038/s41433-023-02433-y |
Ejemplares similares
-
Reviewing the Pathophysiology Behind the Advances in the Management of Giant Cell Arteritis
por: Al-Mousawi, Alia Z., et al.
Publicado: (2019) -
Profile of tocilizumab and its potential in the treatment of giant cell arteritis
por: Mollan, Susan Patricia, et al.
Publicado: (2018) -
European Headache Federation recommendations for neurologists managing giant cell arteritis
por: Mollan, S. P., et al.
Publicado: (2020) -
Giant cell arteritis complicated by acute pancreatitis: a case report
por: Seneviratne, Deepthi Renuka, et al.
Publicado: (2008) -
Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)